CompletedNot Applicable

Visual Outcomes Following Bilateral Implantation of the Vivity Toric Intraocular Lens

Malaysia30 participantsStarted 2022-04-01

Plain-language summary

The objective of this study was to evaluate the clinical and patient reported outcomes after bilateral implantation of the AcrySof™ IQ Vivity™ Toric intraocular lens.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * patients aged 18 years or older * bilateral significant cataracts * bilateral significant corneal astigmatism Exclusion Criteria: * previous refractive surgery * amblyopia * strabismus * any ocular co-morbidity which could impact on final visual acuity * pre-existing zonular weakness * capsular instability or compromise

What they're measuring

Binocular UDVA

Timeframe: 3 months

Binocular UIVA

Timeframe: 3 months

Binocular UNVA

Timeframe: 3 months

Trial details

NCT IDNCT06196593

SponsorLEC Eye Centre

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2023-04-30

View on ClinicalTrials.gov More Cataract Senile trials